Compare KYN & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KYN | AXGN |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | N/A | 2013 |
| Metric | KYN | AXGN |
|---|---|---|
| Price | $14.16 | $40.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $42.33 |
| AVG Volume (30 Days) | 370.3K | ★ 1.6M |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | ★ 8.99% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | N/A | $20.57 |
| Revenue Next Year | N/A | $16.68 |
| P/E Ratio | $19.92 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $11.31 | $11.25 |
| 52 Week High | $14.70 | $46.95 |
| Indicator | KYN | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 56.81 | 42.00 |
| Support Level | $13.62 | $39.65 |
| Resistance Level | $14.35 | $44.83 |
| Average True Range (ATR) | 0.25 | 2.67 |
| MACD | 0.07 | -0.47 |
| Stochastic Oscillator | 85.20 | 17.16 |
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.